Zone7 is a technology company.
Zone7 has raised $11.0M across 2 funding rounds.
Key people at Zone7.
Zone7 has raised $11.0M in total across 2 funding rounds.
Key people at Zone7.
Zone7 has raised $11.0M in total across 2 funding rounds.
Zone7's investors include Amara VC, Blumberg Capital, Company Capital, Mohr Davidow Ventures, Mouro Capital, MS&AD Ventures, Plug & Play Ventures, TCV, Craig Shapiro, Fifth Wall, First Round Capital, Foundation Capital.
Zone7 is an AI-powered platform that analyzes disparate datasets to predict injury risks, optimize load management, and enhance human performance for elite sports teams and organizations. It serves professional leagues like EPL, MLS, NFL, La Liga, Serie A, and clients in rugby, cycling, basketball, American football, women's football, and military sectors, solving the problem of athlete downtime through proactive insights and recommendations for peak performance and injury prevention[1][2][3][4]. Founded in 2017 and headquartered in Palo Alto, CA, with offices in Tel Aviv and London, Zone7 has raised $10.5M in funding, including a $2.5M seed round, and was acquired by svexa in April 2024 to form an end-to-end AI suite for sports, military, and wellbeing[1][2][3].
As part of svexa, Zone7 now integrates device-agnostic AI for injury forecasting, future risk simulation, data integrity, and custom research, trusted by teams like Liverpool FC, SSC Napoli, and LAFC, which improved availability via AI-informed load management[3][4].
Zone7 was founded in 2017 by CEO Tal Brown and CTO Eyal Eliakim in Palo Alto, California, emerging from a need to leverage AI for athlete durability in professional sports[1][2]. The idea stemmed from analyzing vast datasets—over 200 million hours of athletic action—to detect patterns and provide proactive recommendations, initially targeting injury prevention in high-stakes environments like EPL, MLS, and NFL[1]. Early traction came via a $2.5M seed round in 2019 led by Resolute Ventures, with participation from UpWest, Amicus Capital, and athletes, enabling expansion to NCAA and pro teams[2]. A pivotal moment arrived in April 2024 when Zone7 joined svexa, combining its analytics with svexa's algorithms for broader human performance applications beyond sports[3].
Zone7 rides the wave of AI-driven human performance optimization, capitalizing on surging injury rates in elite sports (e.g., top European leagues) amid data explosion from wearables and biometrics[3][4][5]. Timing aligns with post-pandemic focus on athlete availability, insurer interest in AI for risk mitigation, and expansion to military/government, influencing sports science by standardizing predictive analytics across fragmented datasets[1][3]. It shapes the ecosystem by partnering with leagues and enabling data-sharing scale no single club can match, potentially disrupting sports insurance and wellness tech[4].
Zone7's svexa integration positions it to dominate AI human uptime across sports, military, and corporate wellness, with trends like rising injury burdens and advanced wearables accelerating adoption. Expect deeper military partnerships, insurance disruptions via predictive tools, and global expansion leveraging its API model. As the go-to for mitigating risk in high-performance worlds, Zone7 exemplifies AI's shift from reactive to proactive durability[3][4].
Zone7 has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2021 | $8.0M Series A | Amara VC, Blumberg Capital, Company Capital, Mohr Davidow Ventures, Mouro Capital, MS&AD Ventures, Plug & Play Ventures, TCV | |
| Feb 1, 2019 | $3.0M Seed | Craig Shapiro, Fifth Wall, First Round Capital, Foundation Capital, Lowercarbon Capital, SciFi VC, Don Hutchison, Farhad Mohit, Matt Mazzeo |
